These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 5395883

  • 21. [LATS(long-acting thyroid stimulator): recent development].
    Shishiba Y.
    Naika; 1971; 28(1):48-52. PubMed ID: 4935654
    [No Abstract] [Full Text] [Related]

  • 22. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
    Burke G, Silverstein GE.
    JAMA; 1969 Nov 10; 210(6):1051-8. PubMed ID: 4900342
    [No Abstract] [Full Text] [Related]

  • 23. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
    Romaldini JH, Pinchera A, Fenzi GF, Grasso L, Raccis E, Mariotti S, Baschieri L.
    Folia Endocrinol; 1974 Feb 10; 27(1):110-6. PubMed ID: 4549507
    [No Abstract] [Full Text] [Related]

  • 24. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
    Hennemann G, Dolman A, Docter R, De Reus A, Van Zijl J.
    J Clin Endocrinol Metab; 1975 Jun 10; 40(6):935-41. PubMed ID: 1173367
    [Abstract] [Full Text] [Related]

  • 25. [Etiology of Basedow's disease, with special reference to LATS].
    Nagata K.
    Naika Hokan; 1969 Jul 15; 16(7):297-317. PubMed ID: 4901097
    [No Abstract] [Full Text] [Related]

  • 26. LATS protector and abnormal thyroid stimulation in diffuse toxic goitre.
    Stewart RD.
    N Z Med J; 1975 Jan 08; 81(531):24. PubMed ID: 1055311
    [No Abstract] [Full Text] [Related]

  • 27. [Pathogenesis of Basedow's disease].
    Wuttke H.
    Fortschr Med; 1978 Dec 07; 96(46):2325-8. PubMed ID: 581489
    [Abstract] [Full Text] [Related]

  • 28. Ophthalmic Graves' disease. Diagnosis and pathogenesis.
    Hall R, Kirkham K, Doniach D, el-Kabir D.
    Lancet; 1970 Feb 21; 1(7643):375-8. PubMed ID: 4189686
    [No Abstract] [Full Text] [Related]

  • 29. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
    Hopf U, Fiek T, Grün R, Zuschneid W.
    J Clin Lab Immunol; 1982 Oct 21; 9(1):49-53. PubMed ID: 6757440
    [Abstract] [Full Text] [Related]

  • 30. [LATS-the extrapituitary thyroid stimulator and its role in the etiology and pathogenesis of Graves-Basedow disease].
    Nauman J, Nauman A.
    Pol Arch Med Wewn; 1969 Oct 21; 43(4):1427-32. PubMed ID: 5395131
    [No Abstract] [Full Text] [Related]

  • 31. The long-acting thyroid stimulator: its role in Graves' disease.
    McKenzie JM.
    Recent Prog Horm Res; 1967 Oct 21; 23():1-46. PubMed ID: 4174931
    [No Abstract] [Full Text] [Related]

  • 32. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
    Studer H.
    Schweiz Med Wochenschr; 1967 May 13; 97(19):622-3. PubMed ID: 5632362
    [No Abstract] [Full Text] [Related]

  • 33. Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator.
    Dirmikis S, Munro DS.
    J Endocrinol; 1975 Mar 13; 64(3):29P-30P. PubMed ID: 1173370
    [No Abstract] [Full Text] [Related]

  • 34. Radioimmunological studies on the long-acting thyroid stimulator.
    Pinchera A, Rovis L, Grasso L, Liberti P, Martino E, Fenzi GF, Baschieri L.
    Endocrinology; 1970 Aug 13; 87(2):217-25. PubMed ID: 4193237
    [No Abstract] [Full Text] [Related]

  • 35. [An antibody called LATS].
    Letonturier P, Tourneur R.
    Nouv Presse Med; 1975 Jan 18; 4(3):177-9. PubMed ID: 1079340
    [No Abstract] [Full Text] [Related]

  • 36. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
    Furth ED, Dentinger M.
    Endocrinology; 1971 Jul 18; 89(1):310-5. PubMed ID: 4103749
    [No Abstract] [Full Text] [Related]

  • 37. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A, Liberti P, De Santis R, Grasso L, Martino E, Baschieri L.
    J Clin Endocrinol Metab; 1967 Dec 18; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract] [Full Text] [Related]

  • 38. [Parallel study of the thyrostimulating factor with prolonged action (LATS) and of circulating anti-thyroglobulin antibodies. Preliminary results].
    Liberti P, De Santis R, Grasso L, Martino E, Pinchera A, Baschieri L.
    Folia Endocrinol; 1966 Dec 18; 19(6):659-66. PubMed ID: 6014021
    [No Abstract] [Full Text] [Related]

  • 39. The long-acting thyroid stimulator and thyroid disease.
    Kriss JP.
    Adv Intern Med; 1970 Dec 18; 16():135-54. PubMed ID: 4247613
    [No Abstract] [Full Text] [Related]

  • 40. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T, Arreaza G, Nishikawa M, Resetkova E, Jamieson C, Tamai H, Volpé R.
    Clin Invest Med; 1997 Feb 18; 20(1):5-15. PubMed ID: 9013039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.